Please ensure Javascript is enabled for purposes of website accessibility

Class-Action Lawsuit Against HEXO Dismissed "In Its Entirety"

By Rich Duprey - Mar 10, 2021 at 1:46PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The judge's decision should clear one obstacle from the marijuana producer's path forward.

A class-action lawsuit filed against marijuana producer HEXO (HEXO 1.58%) for supposedly making material misstatements to investors and omitting material information about revenue, supply agreements, and facilities it acquired has been dismissed "in its entirety."

According to HEXO, the federal court for the Southern District of New York agreed with its assertion that the plaintiffs "failed to allege actionable misstatements or omissions" under U.S. securities laws, while also rejecting the contention HEXO engaged in fraudulent or reckless conduct over its disclosures.

The marijuana grower did note, however, that while the suit was completely dismissed, the plaintiffs have the right to appeal the decision.

Woman examining marijuana plant

Image source: Getty Images

The plaintiffs leveled a number of the charges against HEXO, among them accusing it of improperly reporting inventory levels because it failed to write down obsolete product that no longer held value, engaging in channel-stuffing to inflate its revenue to meet guidance, and cultivating marijuana at a Niagara facility that it acquired from Newstrike, which reportedly did not secure the appropriate licenses from Health Canada.

The lawsuits were filed against HEXO after it provided preliminary revenue results for its fiscal 2019 fourth quarter that were nearly 50% lower than the guidance it had previously issued, and withdrew the guidance it had served up for its fiscal 2020 (which ended July 31).

HEXO described the 60-page decision from the court as a "thorough opinion" that dismissed the plaintiffs' case by "emphatically rejecting their arguments." If the decision stands, it will allow HEXO to get on with building its global marijuana brand while reducing its litigation costs.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

HEXO Stock Quote
HEXO
HEXO
$0.26 (1.58%) $0.00

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
332%
 
S&P 500 Returns
118%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/26/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.